JSM 2004 - Toronto

Abstract #301827

This is the preliminary program for the 2004 Joint Statistical Meetings in Toronto, Canada. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2004); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.


Back to main JSM 2004 Program page



Activity Number: 381
Type: Contributed
Date/Time: Wednesday, August 11, 2004 : 2:00 PM to 3:50 PM
Sponsor: Section on Bayesian Statistical Science
Abstract - #301827
Title: Applications of Predictive Probabilities in Phase II Cancer Clinical Trials
Author(s): Diane D. Liu*+ and J. Jack Lee
Companies: University of Texas M.D. Anderson Cancer Center and University of Texas M.D. Anderson Cancer Center
Address: 1515 Holcombe Blvd., Unit 447, Houston, TX, 77030,
Keywords: Bayesian methods ; flexible monitoring scheme ; early termination ; efficiency ; robustness
Abstract:

A Bayesian predictive probability approach is proposed as an alternative to the commonly used two- or three-stage designs in phase II cancer clinical trials. The new design allows flexible and more frequent monitoring of the trial outcomes. Early termination of the trial can be reached when the interim data indicate that the experimental regimen is not promising. Even with more frequent monitoring, the predictive probability approach can still possess good frequentist's properties by controlling Type I and Type II errors. A bidimensional search algorithm is implemented to determine the design parameters. Exact computation and simulation studies demonstrate that the predictive probability approach is more efficient than the traditional multistage designs. The predictive probability design not only is more adaptable in evaluating the study outcome but also remains robust even when deviations occur in monitoring cohorts of patients as specified in the trial design. Examples will be given to illustrate the statistical properties of various design settings.


  • The address information is for the authors that have a + after their name.
  • Authors who are presenting talks have a * after their name.

Back to the full JSM 2004 program

JSM 2004 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2004